Multimodal Retinal Imaging of Cerebrovascular Stroke
OCTAV
1 other identifier
observational
62
1 country
1
Brief Summary
The hypothesis is that in patients with stroke, abnormalities of retinal microvascularization shown on color fundus photography and the depletion of retinal capillary density evaluated by OCT-A are markers of acute impairment of microcirculation of the central nervous system and are correlated with lesions on brain imaging. Patients hospitalized for stroke MRI-confirmed, will be included. An ophthalmologic assessment including color fundus photography (CFP) and OCT-A will be carried out after stabilization and at 3 months follow-up. Outcomes assessor will be blinded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2019
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 24, 2019
CompletedFirst Posted
Study publicly available on registry
May 28, 2019
CompletedStudy Start
First participant enrolled
November 15, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 15, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 15, 2022
CompletedMarch 3, 2022
March 1, 2022
2 years
May 24, 2019
March 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Presence of an anomaly in color fundus photography or an anomaly of retinal capillary density to OCT-A
3 months
Interventions
Included patients will have an ophthalmologic assessment (OCT-A and CPF) after stabilization and at 3 months follow-up.
Eligibility Criteria
Acute patients with a stroke will be included
You may qualify if:
- Acute ischemic stroke
- With cerebral microangiopathy (defined by a SVD score \> 1)
You may not qualify if:
- Acute hemorrhagic stroke
- Anophthalmia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fondation A de Rothschild
Paris, 75019, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 24, 2019
First Posted
May 28, 2019
Study Start
November 15, 2019
Primary Completion
November 15, 2021
Study Completion
February 15, 2022
Last Updated
March 3, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share